Insiders Ipsen

Equities

Real-time Euronext Paris Other stock markets 06:51:24 2024-05-10 am EDT			5-day change	1st Jan Change
119.4 ^EUR	-0.17%		+4.28%	+10.66%

May. 02	Ipsen Announces Executive Changes	CI
May. 02	Ipsen: new President for North America	CF

Ipsen Announces Executive Changes	May. 02	CI
Ipsen: new President for North America	May. 02	CF
Ipsen: appointment of an independent director	23-09-04	CF
Ipsen appoints new R&D Director	23-09-01	CF
Ipsen appoints new Medical Director	23-04-24	CF
France's Ipsen Names Chief Medical Officer	23-04-24	MT
Ipsen Appoints Sandra Silvestri as EVP, Chief Medical Officer and Head of Global Medical Affairs, Patient Safety and Patient Affairs, Effective 5 May 2023	23-04-24	CI
Cann Group Appoints CEO	23-01-09	MT
OSE Immunotherapeutics Appoints Ipsen Executive As CEO	22-07-14	MT
Ipsen Appoints Catherine Abi-Habib as EVP Strategy, Transformation, and Digital	22-02-16	CI
Ipsen Nominates Karen Witts as New Independent Board Member	22-01-21	CI
Ipsen Appoints Stewart Campbell as Executive Vice President and President of North America	21-11-03	CI
Ipsen Appoints Mari Scheiffele as EVP and President, Specialty Care International, Effective November 1, 2021	21-10-11	CI
Mirati Therapeutics : taps industry veteran Meek as CEO	21-09-20	RE
Ipsen Appoints Gwenan White as Executive Vice President Communications and Public Affairs	21-01-21	CI
Ipsen Appoints Philippe Lopes-Fernandes as Executive Vice President, Chief Business Officer	20-09-25	CI
Ipsen Group Announces Executive Appointments	20-09-03	CI
Ipsen Announces Management Changes	20-05-29	CI
Ipsen Announces Board Changes	20-05-29	CI
Ipsen S.A. Appoints Steven Hildemann as Executive Vice President, Chief Medical Officer, Head of Global Medical Affairs and Pharmacovigilance, Effective March 1, 2020	20-01-14	CI

No results for this search

IPSEN : Better-than-expected Q1; guidance unchanged

April 24, 2024 at 10:50 am EDT